Ravi Thakur, Ph.D., is an Assistant Professor at Christ University in Bengaluru, India. His research focuses on understanding the metabolic changes that contribute to therapy resistance and metastasis in pancreatic cancer. He studies the metabolic crosstalk between tumors and their microenvironment, with a specific focus on the interactions between tumor cells and cancer-associated fibroblasts, NK cells, and macrophages.
Before joining Christ University, Dr. Thakur was a Research Assistant Professor at the University of Oklahoma Health Science Center in the USA. He is currently establishing a research group in India to investigate local malignancies while continuing his work on pancreatic cancer. His current research themes include:
1. Epigenetic and metabolic changes that drive cell fate decisions in cancer and aging.
2. Developing next-generation CAR-NK and NKT cells.
3. Identifying and targeting factors that influence cell-fate decisions and metastasis.
4. Delineating the role of oncometabolites in the tumor microenvironment.
5. Investigating the role of iron and redox homeostasis in cell fate decisions and cancer stem cell phenotype.
6. Metabolic alterations in diabetic foot healing
Ravi Thakur, Ph.D., is an Assistant Professor at Christ University in Bengaluru, India. His research focuses on understanding the metabolic changes that contribute to therapy resistance and metastasis in pancreatic cancer. He studies the metabolic crosstalk between tumors and their microenvironment, with a specific focus on the interactions between tumor cells and cancer-associated fibroblasts, NK cells, and macrophages.
Before joining Christ University, Dr. Thakur was a Research Assistant Professor at the University of Oklahoma Health Science Center in the USA. He is currently establishing a research group in India to investigate local malignancies while continuing his work on pancreatic cancer. His current research themes include:
1. Epigenetic and metabolic changes that drive cell fate decisions in cancer and aging.
2. Developing next-generation CAR-NK and NKT cells.
3. Identifying and targeting factors that influence cell-fate decisions and metastasis.
4. Delineating the role of oncometabolites in the tumor microenvironment.
5. Investigating the role of iron and redox homeostasis in cell fate decisions and cancer stem cell phenotype.
6. Metabolic alterations in diabetic foot healing